JAKARTA - In the midst of a significant decline in revenue from COVID, PT Bundamedik Tbk (BMHS) was able to record non-COVID revenues of IDR 375 billion during the first quarter of 2022, which is the company's highest non-COVID revenue figure in the last 2 years. The non-COVID revenue increased 12.6% compared to Q1 2021
This revenue was supported by the significant development of the company's core business, especially the Morula IVF business unit, the market leader for IVF services in Indonesia which continues to expand nationally, as well as Diagnos which is growing rapidly through its ability to develop market networks in non-COVID test services through strategic partnership strategy.
BMHS President Director Mesha Rizal Sini explained, "There are many strategic adjustments that health service providers must make during the pandemic. However, apart from this, we are always consistent with the non-COVID core business development strategy so that under any circumstances we are ready with solid business fundamentals. Now along with the easing of the COVID-19 pandemic, this consistency has also provided our readiness to face the dynamics of the industrial landscape. The achievement of the non-COVID business in the first quarter of this year is an extraordinary start for our efforts to continue to quickly adapt to meet the needs of public health services in the future, especially along with increasing awareness of health, reflected in the significant increase in the number of non-COVID tests that people do in our ecosystem.”
During the first quarter of 2022, the number of non-COVID tests increased by 38% YoY. This increase was successful due to the existence of a business model that is supported by the contribution of outlets and branches as well as the internal ecosystem in Bunda Hospital services. The number and distribution of outlets have also increased quite rapidly. There are now 38 Diagnos outlets, an increase of 2 times compared to the figure in the first quarter of 2021. Going forward, Diagnos development will be intensified by adding 5 outlets and branches in several regions.
In order to maintain the growth momentum in the first quarter of 2022, BMHS is ready to continue its business focus through the three strategic pillars that have been launched, including expanding the ecosystem, deepening strategic partnerships, and strengthening core business. (LM)